These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20865895)

  • 1. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex-rocuronium dosing.
    Kopman AF
    Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
    de Boer HD; Driessen JJ; van Egmond J; Booij LH
    Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rapid sequence induction in a patient with Steinert myotonic dystrophy: Interest of the association of high doses of rocuronium and sugammadex].
    Pellegrini L; Mercier MF; Cornese A; Blasco V; Albanèse J
    Ann Fr Anesth Reanim; 2012 Feb; 31(2):155-7. PubMed ID: 22154451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rocuronium and sugammadex on neuromuscular blockade in a child with congenital myotonic dystrophy type 1.
    Pickard A; Lobo C; Stoddart PA
    Paediatr Anaesth; 2013 Sep; 23(9):871-3. PubMed ID: 23763618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex use experience in pediatric oncology].
    Matinyan NV; Saltanov AI; Mareeva AA
    Anesteziol Reanimatol; 2013; (1):34-7. PubMed ID: 23808251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First human exposure to Org 25969.
    Nigrovic V; Bhatt SB; Amann A
    Anesthesiology; 2006 Aug; 105(2):427; author reply 427. PubMed ID: 16871080
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of sugammadex in a patient with myotonic dystrophy.
    Matsuki Y; Hirose M; Tabata M; Nobukawa Y; Shigemi K
    Eur J Anaesthesiol; 2011 Feb; 28(2):145-6. PubMed ID: 20962659
    [No Abstract]   [Full Text] [Related]  

  • 11. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
    Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
    J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal.
    Porter MV; Paleologos MS
    Anaesth Intensive Care; 2011 Mar; 39(2):299-302. PubMed ID: 21485682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 14. Operating room discharge after deep neuromuscular block reversed with sugammadex compared with shallow block reversed with neostigmine: a randomized controlled trial.
    Putz L; Dransart C; Jamart J; Marotta ML; Delnooz G; Dubois PE
    J Clin Anesth; 2016 Dec; 35():107-113. PubMed ID: 27871505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy.
    Stewart PA; Phillips S; De Boer HD
    Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):226-9. PubMed ID: 22947194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.
    Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H
    J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Sugammadex in Patients With Obesity: A Pooled Analysis.
    Monk TG; Rietbergen H; Woo T; Fennema H
    Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Suxamethonium and myotonic dystrophy type 1].
    Nivoche Y; Bruneau B; Dahmani S
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):571. PubMed ID: 22677059
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthesia for laparoscopic surgery in a patient with myotonic dystrophy (Steinert's disease): beneficial use of sugammadex, but incorrect use of pethidine: a case report.
    Mavridou P; Dimitriou V; Margaritis A; Manataki A
    Acta Anaesthesiol Belg; 2011; 62(2):101-4. PubMed ID: 21919378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
    Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
    Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.